Out of 400+ applications, we've selected 180+ PIC semifinalists. These ventures represent all 13 Harvard schools and are one step closer to winning a share of $500,000+ in Bertarelli Foundation funding.
2026
Democratizing access to life-saving medical equipment in emerging markets through flexible sharing, leasing, and on-demand solutions.
Predicting heart arrhythmias hours in advance through an AI platform that gives clinicians critical intervention time to save lives.
Using AI to detect skin diseases and cancer from a selfie while delivering personalized skincare insights and recommendations.
Accelerating patient enrollment in clinical trials by automating how sites find, contact, and enroll eligible patients.
Automating EMR matching to cut screening time, reduce protocol delays, support clinicians, and bring needed treatments to millions of patients faster.
Running Jinja City’s first community-based 911 system to make emergency maternal care just one call away in rural Uganda.
Revolutionizing Indonesia’s silent oral health crisis with dental screenings, oral health education, and accessible treatment referrals for children.
Revolutionizing drug-resistant epilepsy surgery with an FDA-path clinical decision support platform.
Developing a next-generation gene insertion platform for the treatment of genetic and age-associated diseases.
Redefining cystoscopy for bladder cancer surveillance to be more accessible, convenient, and comfortable for patients.
Partnering with indigenous communities to co-design culturally grounded, evidence-based approaches to advance health equity.
Using 3D bioprinting to create custom arteries for bypass surgery, aiming to replace traditional autologous grafts.
Providing a hospital-integrated school that supports children with chronic illness, ensuring educational equity and closing learning gaps so no child is left behind.
Harnessing AI and voice technology to detect early signs of cognitive impairment.
The remote patient monitoring platform built for sleep medicine: helping practices monitor CPAP adherence, close care gaps, and get reimbursed for it.
Accelerating drug discovery by leveraging nanopore technology to target previously challenging proteins.
Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
Transforming neurocritical patient care by providing real-time, noninvasive brain monitoring through a wearable device.
Building a social network for academics to share research, track impact, explore 500M+ papers, and use AI to engage with the global science ecosystem.
Developing an AI-powered wearable photonic device for at-home heart failure monitoring through real-time, multi-biomarker detection.
Engineering protein nanoparticles for targeted delivery of gene and protein therapeutics, advancing novel treatments for genetic diseases.
Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
Delivering the first button-activated tourniquet that gives first responders confidence they’re saving lives correctly every time, eliminating the 70% failure rate.
Enabling high-bandwidth human–AI collaboration by allowing agents to understand user intent beyond text and command-based interactions.
The Harvard Innovation Labs is at the center of a thriving innovation ecosystem at Harvard, in Greater Boston, and around the world.
Explore Our Ecosystem